Our Consultants, Your Partners
Susan Dana Jones, Ph.D.
Vice President and Senior Consultant
Susan Dana Jones is a seasoned biotechnology entrepreneur with experience in biopharmaceutical discovery, product development, and strategic planning. She co-founded two successful biotechnology companies and has managed multiple discovery and product development programs. Dr. Jones is a subject matter expert in cell line development and characterization and is a leader in applying the principles of Quality by Design (QbD) to early stage biopharmaceutical development programs. She currently advises clients on the advancement of product candidates from research through development. Dr. Jones also assists clients in the application of GMP regulations and preparation of regulatory submissions as well as performing technical due diligence in support of investors or mergers and acquisitions. Dr. Jones is a frequently invited speaker at industry conferences and symposia and also serves as a guest lecturer at Northeastern University. She is a member of the Board of Directors of Gene Solutions, LLC, the Symphogen A/S Scientific Advisory Board, the Editorial Advisory Board of BioProcess International. Prior to joining BioProcess Technology Consultants, Dr. Jones was Senior Vice President of Corporate Development at Serenex, Inc, where she worked with other senior managers to complete a $15M Series B financing. Prior to Serenex, she was Vice President of Product Development at Waratah Pharmaceuticals and previously held development and management positions of increasing responsibility at Peptimed Inc., Virus Research Institute (now Celldex Immunotherapeutics), IntraImmune Therapies Inc., and Dyax Corp. Dr. Jones received her Bachelor's degree from Harvard University, holds a Ph.D. in Genetics from the University of California, San Francisco, and performed post-doctoral research at the Dana-Farber Cancer Institute of Harvard Medical School.